EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES

Large epidemiological trails shown that hypercholesterolemia is one of the main risk factor of ischemic heart disease (IHD). Correction of the hypercholesterolemia with GmGKoA reductase inhibitors (statins) essentially reduces IHD morbidity and mortality. The lower serum level of low density lipopro...

Full description

Saved in:
Bibliographic Details
Main Author: A. N. Meshkov
Format: Artigo
Language:Inglês
Published: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
hypercholesterolemia
ischemic heart disease
atorvastatin
Online Access:https://www.rpcardio.com/jour/article/view/820
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items